Terms: = Breast cancer AND NCOR2, SMRTE-tau, 9612, ENSG00000196498, SMRTE, TNRC14, TRAC-1, SMRT, CTG26, TRAC1 AND Prognosis
10 results:
1. Screening of organoids derived from patients with breast cancer implicates the repressor ncor2 in cytotoxic stress response and antitumor immunity.
Tsai KK; Huang SS; Northey JJ; Liao WY; Hsu CC; Cheng LH; Werner ME; Chuu CP; Chatterjee C; Lakins JN; Weaver VM
Nat Cancer; 2022 Jun; 3(6):734-752. PubMed ID: 35618935
[TBL] [Abstract] [Full Text] [Related]
2. CUL4B Promotes breast Carcinogenesis by Coordinating with Transcriptional Repressor Complexes in Response to Hypoxia Signaling Pathway.
Huang W; Zhang J; Huo M; Gao J; Yang T; Yin X; Wang P; Leng S; Feng D; Chen Y; Yang Y; Wang Y
Adv Sci (Weinh); 2021 May; 8(10):2001515. PubMed ID: 34026424
[TBL] [Abstract] [Full Text] [Related]
3. Thyroid Hormones, Silencing Mediator for Retinoid and Thyroid Receptors and prognosis in Primary breast cancer.
Nisman B; Allweis TM; Carmon E; Kadouri L; Maly B; Maimon O; Meierovich A; Peretz T
Anticancer Res; 2020 Nov; 40(11):6417-6428. PubMed ID: 33109580
[TBL] [Abstract] [Full Text] [Related]
4. ER-Negative breast cancer Is Highly Responsive to Cholesterol Metabolite Signalling.
Hutchinson SA; Lianto P; Roberg-Larsen H; Battaglia S; Hughes TA; Thorne JL
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31683867
[TBL] [Abstract] [Full Text] [Related]
5. Obesity impacts the regulation of miR-10b and its targets in primary breast tumors.
Meerson A; Eliraz Y; Yehuda H; Knight B; Crundwell M; Ferguson D; Lee BP; Harries LW
BMC Cancer; 2019 Jan; 19(1):86. PubMed ID: 30658617
[TBL] [Abstract] [Full Text] [Related]
6. Evaluating wait times from screening to breast cancer diagnosis among women undergoing organised assessment vs usual care.
Chiarelli AM; Muradali D; Blackmore KM; Smith CR; Mirea L; Majpruz V; O'Malley FP; Quan ML; Holloway CM
Br J Cancer; 2017 May; 116(10):1254-1263. PubMed ID: 28359079
[TBL] [Abstract] [Full Text] [Related]
7. FOXK2 Elicits Massive Transcription Repression and Suppresses the Hypoxic Response and breast cancer Carcinogenesis.
Shan L; Zhou X; Liu X; Wang Y; Su D; Hou Y; Yu N; Yang C; Liu B; Gao J; Duan Y; Yang J; Li W; Liang J; Sun L; Chen K; Xuan C; Shi L; Wang Y; Shang Y
Cancer Cell; 2016 Nov; 30(5):708-722. PubMed ID: 27773593
[TBL] [Abstract] [Full Text] [Related]
8. The molecular diversity of Luminal A breast tumors.
Ciriello G; Sinha R; Hoadley KA; Jacobsen AS; Reva B; Perou CM; Sander C; Schultz N
Breast Cancer Res Treat; 2013 Oct; 141(3):409-20. PubMed ID: 24096568
[TBL] [Abstract] [Full Text] [Related]
9. The prognostic significance of steroid receptor co-regulators in breast cancer: co-repressor ncor2/smrt is an independent indicator of poor outcome.
Green AR; Burney C; Granger CJ; Paish EC; El-Sheikh S; Rakha EA; Powe DG; Macmillan RD; Ellis IO; Stylianou E
Breast Cancer Res Treat; 2008 Aug; 110(3):427-37. PubMed ID: 17902051
[TBL] [Abstract] [Full Text] [Related]
10. Steroid receptor coactivator AIB1 in endometrial carcinoma, hyperplasia and normal endometrium: Correlation with clinicopathologic parameters and biomarkers.
Balmer NN; Richer JK; Spoelstra NS; Torkko KC; Lyle PL; Singh M
Mod Pathol; 2006 Dec; 19(12):1593-605. PubMed ID: 16980945
[TBL] [Abstract] [Full Text] [Related]
